Table 1.
Variables | Baseline CD4+ count in cells/μL, n (%) | |||
---|---|---|---|---|
200–349 (n = 20,827) | 350–499 (n = 4336) | ≥500 (n = 1589) | ||
Sex | ||||
Male | 18,256 | 14,553 (69.88) | 2673 (61.65) | 1030 (64.82) |
Female | 8496 | 6274 (30.12) | 1663 (38.35) | 559 (35.18) |
Age at start of ART (years) | ||||
Mean (std.) | 39.21 (12.91) | 37.89 (11.78) | 36.19 (11.06) | |
15–44 | 19,371 | 14,795 (71.04) | 3300 (76.11) | 1276 (80.30) |
45–59 | 5184 | 4276 (20.05) | 768 (17.71) | 240 (15.10) |
≥60 | 2197 | 1856 (8.91) | 268 (6.18) | 73 (4.59) |
Marital statusa | ||||
Married or living with partners | 16,173 | 12,039 (58.04) | 2944 (68.02) | 1190 (75.03) |
Single, divorced or windowed | 10,483 | 8703 (41.96) | 1384 (31.98) | 996 (24.97) |
HIV transmission mode | ||||
MSM | 4945 | 4383 (21.04) | 463 (10.68) | 99 (6.23) |
Heterosexual | 16,142 | 12,444 (59.75) | 2750 (63.42) | 948 (59.66) |
IDU | 3559 | 2444 (11.73) | 737 (17.00) | 378 (23.79) |
Othersb | 2106 | 1556 (7.47) | 386 (8.90) | 164 (10.32) |
Type of treatment center | ||||
County or higher level hospital | 24,220 | 18,945 (90.96) | 3842 (88.61) | 1433 (90.18) |
Township hospital | 2532 | 1882 (9.04) | 494 (11.39) | 156 (9.82) |
Initial ART regimen | ||||
AZT/d4T+3TC+EFV/NVP | 21,414 | 17,397 (83.53) | 3119 (71.93) | 898 (56.51) |
TDF +3TC+EFV/NVP | 5338 | 3430 (16.47) | 1217 (28.07) | 691 (43.49) |
All demographic and behavioral characteristics included were shown to be statistically significant with respect to differences between the three treatment groups.
Some of the individual counts do not sum to the totals due to missing data.
“Others” indicate that the marital status of participants is unknown.
3TC, lamivudine; ART, antiretroviral therapy; AZT, zidovudine; d4T, stavudine; EFV, efavirenz; IDU, injection drug use; MSM, men who have sex with men; NVP, nevirapine; TDF, tenofovir.